Design, Synthesis, and 2D QSAR Analysis of Some Novel Pyrazolo[1,5‐a]pyrimidine Derivatives as Pim‐1 Kinase Inhibitors for the Treatment of MCF‐7 Breast Cancer

Documenti analoghi

• Multitargeted Anti‐Inflammatory Agents: Novel Pyrazole and Pyrazolo[1,5‐ a ]Pyrimidine Carbonic Anhydrase and COX‐2 Inhibitors With Optimal In Vivo Efficacy and Low Toxicity
  di: Mariam M. Fakhry, et al.
  Pubblicazione: (2025)
• Exploring new quinazolin‐4(3H)‐one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation
  di: Basant T. Ibrahim, et al.
  Pubblicazione: (2024)
• Exploring Pyrazolo[3,4‐ b ]Pyridine and Spiro‐Oxindole Hybrids as Selective CDK2 or EGFR Inhibitors for Targeted Cancer Therapy: Design, Synthesis, and Molecular Modeling Insights
  di: Ahmed K. B. A. W. Farouk, et al.
  Pubblicazione: (2026)
• Comparative Study of Conventional, Grinding, and Microwave‐Assisted Synthesis of Aminopyrazolones and Diaminopyrazoles: Exploring the Antitumor Activity, Dual CDK‐2/CA IX Inhibition Potential, and Apoptosis Induction
  di: Kurls E. Anwer, et al.
  Pubblicazione: (2025)
• Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ b ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLC
  di: Mohamed K. Elgohary, et al.
  Pubblicazione: (2025)